Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anorexia × nabiximols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Marijuana Abuse 3 Pain 2 Neoplasms 2 Recurrence 1 Parasomnias 1 Pancreatic Neoplasms 1 Nausea 1 Glioblastoma 1 Chronic Pain 1 Cachexia 1 Brain Neoplasms 1 Anxiety Disorders 1 Anorexia 1 Advanced Malignant Solid Tumor 1

Interventions

Megestrol Acetate 3 Mirtazapine 2 nabiximols 1 anamorelin 1 Watchful Waiting 1 Thalidomide 1 Observation 1 Megestrol 1 Infliximab 1 Gemcitabine 1 Flurandrenolone 1 EOM613 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03245658 2023-12-18

The Effect of Cannabis in Pancreatic Cancer

University of Copenhagen

Phase 2 Withdrawn

Gastrointestinal

Anorexia, Cachexia, Marijuana Abuse, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡